Tiziano Moccetti
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE).
Sudano I, Mach F, Moccetti T, Burkard T, Fahe C, Delabays A, Rickli H, Keller P, Dopheide J, Bodenmann S, Fiolka T, Ehret G, Spirk D. Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE). Front Cardiovasc Med 2022; 9:953040.
15.07.2022Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE).
15.07.2022Front Cardiovasc Med 2022; 9:953040
Sudano Isabella, Mach François, Moccetti Tiziano, Burkard Thilo, Fahe Christian, Delabays Alain, Rickli Hans, Keller Pierre-Fréderic, Dopheide Jörn, Bodenmann Sereina, Fiolka Tom, Ehret Georg, Spirk David
Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
Tersalvi G, Erne P, Moccetti T, Jeger R, Moccetti M, Eberli F, Roffi M, Rickli H, Radovanovic D, Biasco L, Pedrazzini G. Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry. Cardiology 2020; 145:757-765.
20.08.2020Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
20.08.2020Cardiology 2020; 145:757-765
Tersalvi Gregorio, Erne Paul, Moccetti Tiziano, Jeger Raban, Moccetti Marco, Eberli Franz, Roffi Marco, Rickli Hans, Radovanovic Dragana, Biasco Luigi, Pedrazzini Giovanni
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry
Auricchio A, Notarangelo F, Braun-Dullaeus R, Regoli F, Caputo M, Özkartal T, Zegard A, Martino A, Sticherling C, Conti M, Honarbakhsh S, Moccetti T, Casu G, Rinaldi C, Brugada P, Haïssaguerre M, Brugada J, Heidbuchel H, Pappone C, Curti M, Klersy C, Derval N, Haugaa K, Levinstein M, Michowitz Y, Márquez M, Stokke M, Letsas K, Calo' L, Burri H, Frontera A, Schaer B, Arbelo E, de Asmundis C, Ciconte G, Lambiase P, Belhassen B, Leyva F, Porter B, Saenen J, de Potter T, Geller J, Medeiros-Domingo A, Sarquella Brugada G, Rordorf R, Luani B, Zardini M, Ammann P, Berne P, Zacà V, Conte G. Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry. Europace 2019; 21:1670-1677.
01.11.2019Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry
01.11.2019Europace 2019; 21:1670-1677
Auricchio Angelo, Notarangelo Francesca, Braun-Dullaeus Rüdiger C, Regoli François, Caputo Maria Luce, Özkartal Tardu, Zegard Abbasin, Martino Annamaria, Sticherling Christian, Conti Manuel, Honarbakhsh Shohreh, Moccetti Tiziano, Casu Gavino, Rinaldi Christopher A, Brugada Pedro, Haïssaguerre Michel, Brugada Josép, Heidbuchel Hein, Pappone Carlo, Curti Moreno, Klersy Catherine, Derval Nicolas, Haugaa Kristina H, Levinstein Moises, Michowitz Yoav, Márquez Manlio F, Stokke Mathis K, Letsas Kostantinos P, Calo' Leonardo, Burri Haran, Frontera Antonio, Schaer Beat, Arbelo Elena, de Asmundis Carlo, Ciconte Giuseppe, Lambiase Pier, Belhassen Bernard, Leyva Francisco, Porter Bradley, Saenen Johan, de Potter Tom, Geller Johann-Christoph, Medeiros-Domingo Argelia, Sarquella Brugada Georgia, Rordorf Roberto, Luani Blerim, Zardini Marco, Ammann Peter, Berne Paola, Zacà Valerio, Conte Giulio
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
Biasco L, Erne P, Moccetti T, Jeger R, Eberli F, Roffi M, Rickli H, Moccetti M, Radovanovic D, Pedrazzini G. New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. Rev Esp Cardiol (Engl Ed) 2018
10.04.2018New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
10.04.2018Rev Esp Cardiol (Engl Ed) 2018
Biasco Luigi, Erne Paul, Moccetti Tiziano, Jeger Raban, Eberli Franz, Roffi Marco, Rickli Hans, Moccetti Marco, Radovanovic Dragana, Pedrazzini Giovanni
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
Vassalli G, Pedrazzini G, Pfisterer M, Kaiser C, Moccetti T, Bonetti P, Bertel O, Hornig B, Rickli H, Eberli F, Erne P, Galatius S, De Servi S, Klersy C, BASKET-PROVE Investigators. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial. Am Heart J 2015; 173:1-7.
01.12.2015Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
01.12.2015Am Heart J 2015; 173:1-7
Vassalli Giuseppe, Pedrazzini Giovanni, Pfisterer Matthias, Kaiser Christoph, Moccetti Tiziano, Bonetti Piero, Bertel Osmund, Hornig Burkhard, Rickli Hans, Eberli Franz, Erne Paul, Galatius Soeren, De Servi Stefano, Klersy Catherine, BASKET-PROVE Investigators
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
Kaiser C, Vuillomenet A, Steiner M, von Felten S, Vogt D, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M, Weilenmann D, Rickli H, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz D, Pedrazzini G, Moccetti T, BASKET-PROVE II study group. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Circulation 2014; 131:74-81.
19.11.2014Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
19.11.2014Circulation 2014; 131:74-81
Kaiser Christoph, Vuillomenet André, Steiner Martin, von Felten Stefanie, Vogt Deborah R, Wadt Hansen Kim, Rickenbacher Peter, Conen David, Müller Christian, Buser Peter, Hoffmann Andreas, Pfisterer Matthias, Weilenmann Daniel, Rickli Hans, Galatius Soeren, Jeger Raban, Gilgen Nicole, Skov Jensen Jan, Naber Christoph, Alber Hannes, Wanitschek Maria, Eberli Franz, Kurz David J, Pedrazzini Giovanni, Moccetti Tiziano, BASKET-PROVE II study group
Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience
Pedrazzini G, Erne P, Rickli H, Windecker S, Urban P, Eberli F, Moccetti T, Sürder D, Vassalli G, Radovanovic D, AMIS Plus Investigators. Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience. JACC Cardiovasc Interv 2011; 4:627-33.
01.06.2011Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience
01.06.2011JACC Cardiovasc Interv 2011; 4:627-33
Pedrazzini Giovanni B, Erne Paul, Rickli Hans, Windecker Stephan, Urban Philip, Eberli Franz, Moccetti Tiziano, Sürder Daniel, Vassalli Giuseppe, Radovanovic Dragana, AMIS Plus Investigators